CCN2 and diabetic kidney disease: Furthermore, blockade of mTOR signaling with rapamycin was also able to inhibit CRP and /or high glucose-induced upregulation of collagen I and CTGF expression (Fig. 8F,G), demonstrating mTOR signaling as a central mechanism by which CRP promotes diabetic kidney disease in T2DN.